Venture Life Group Valuation Multiples

Discover Venture Life Group's revenue and EBITDA valuation multiples and M&A history, alongside public comparables like FitLife Brands, Chong Kun Dang Holdings, Vita Life Sciences, Promopharm and more.

Venture Life Group Overview

About Venture Life Group

Venture Life Group PLC is an international consumer self-care company. The company focuses on the development and commercialization of healthcare products, including oral care products, food supplements, medical devices, and cosmetics. The company operates in two segments: Venture Life Brands, which includes sales of branded healthcare and cosmetics products, and Customer Brands, which includes sales of products and services under contract development and manufacturing agreements. Its geographical segments include the United Kingdom, Ireland, Germany, Netherlands, France, the Rest of Europe, other countries, and the Rest of the World.


Founded

2005

HQ

United Kingdom

Employees

58

Financials (LTM)

Revenue: $50M
EBITDA: $9M

EV

$68M

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Venture Life Group Financials

Venture Life Group reported last 12-month revenue of $50M and EBITDA of $9M.

In the same LTM period, Venture Life Group generated $14M in gross profit, $9M in EBITDA, and $21M in net income.

Revenue (LTM)


Venture Life Group P&L

In the most recent fiscal year, Venture Life Group reported revenue of $36M and EBITDA of $6M.

Venture Life Group is unprofitable as of last fiscal year, with gross margin of 46%, EBITDA margin of 16%, and net margin of (1%).

See analyst estimates for Venture Life Group
LTMLast FY202320242025202620272028
Revenue$50M$36M$50M$36M$46M
Gross Profit$14M$16M$21M$16M$10M
Gross Margin27%46%42%46%21%
EBITDA$9M$6M$9M$6M$8M
EBITDA Margin18%16%18%16%17%
EBIT Margin6%12%9%12%5%
Net Profit$21M($422K)$270K($422K)$22M
Net Margin42%(1%)1%(1%)47%
Net Debt-$27M---

Financial data powered by Morningstar, Inc.

Venture Life Group Stock Performance

Venture Life Group has current market cap of $113M, and enterprise value of $68M.

Market Cap Evolution


Venture Life Group's stock price is $0.93.

Venture Life Group share price increased by 6.9% in the last 30 days, and by 16.6% in the last year.

See more trading valuation data for Venture Life Group
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$68M$113M-0.2%6.9%20.5%16.6%$-0.00

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Venture Life Group Valuation Multiples

Venture Life Group trades at 1.4x EV/Revenue multiple, and 7.7x EV/EBITDA.

See NTM and 2027E valuation multiples for Venture Life Group

EV / Revenue (LTM)


Venture Life Group Financial Valuation Multiples

As of July 19, 2026, Venture Life Group has market cap of $113M and EV of $68M.

Venture Life Group has a P/E ratio of 5.5x.

LTMLast FY202320242025202620272028
EV/Revenue1.4x1.9x1.4x1.9x1.5x
EV/EBITDA7.7x11.8x7.6x11.8x8.7x
EV/EBIT22.2x16.2x14.9x16.2x30.5x
EV/Gross Profit5.0x4.2x3.3x4.2x6.9x
P/E5.5xn/mn/mn/m5.2x
EV/FCF10.2x6.1x7.0x6.1x10.6x

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Venture Life Group Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Venture Life Group Margins & Growth Rates

Venture Life Group grew revenue by 30% and EBITDA by 35% in the last fiscal year.

In the most recent fiscal year, Venture Life Group reported gross margin of 46%, EBITDA margin of 16%, and net margin of (1%).

See estimated margins and future growth rates for Venture Life Group

Venture Life Group Margins

Last FY202420252026202720282029
Gross Margin46%46%21%41%
EBITDA Margin16%16%17%20%
EBIT Margin12%12%5%9%
Net Margin(1%)(1%)47%28%
FCF Margin31%31%14%12%

Venture Life Group Growth Rates

FY+1/FY23/2424/2525/2626/2727/2828/29
Revenue Growth30%(28%)30%34%
Gross Profit Growth(39%)(21%)(39%)160%
EBITDA Growth35%(35%)35%58%
EBIT Growth(47%)(8%)(47%)162%
Net Profit Growth(5266%)(257%)(5266%)(20%)
FCF Growth(42%)14%(42%)17%

Data powered by FactSet, Inc. and Morningstar, Inc.

Venture Life Group Operational KPIs

Venture Life Group's revenue per employee in the last FY averaged $0.6M, while opex per employee averaged $0.2M for the same period.

Venture Life Group's Rule of 40 is 54% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Venture Life Group's Rule of X is 105% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

Access forward-looking KPIs for Venture Life Group
LTMLast FY20232024202620272028
Rule of 4067%54%--
Bessemer Rule of X140%105%--
Revenue per Employee-$0.6M--
Opex per Employee-$0.2M--
R&D Expenses to Revenue-1%0%1%
Opex to Revenue-34%33%34%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

Venture Life Group Competitors

Venture Life Group competitors include FitLife Brands, Chong Kun Dang Holdings, Vita Life Sciences, Promopharm, Hofseth BioCare, Hyundai Bioland Co, Enzymatica, Biome Australia, Provexis and Niagen Bioscience.

Most Venture Life Group public comparables operate across Nutraceuticals & Cosmeceuticals.

EV/RevenueEV/EBITDA
Last FYLTM2027ELast FYLTM2027E
FitLife Brands1.8x1.5x10.3x9.7x
Chong Kun Dang Holdings0.6x-4.7x-
Vita Life Sciences1.1x-6.7x-
Promopharm0.9x-7.4x-
Hofseth BioCare3.8x-(13.6x)-
Hyundai Bioland Co0.7x-5.2x-
Enzymatica9.3x9.3x(11.5x)-
Biome Australia3.0x2.3x87.3x18.4x

This data is available for Pro users. Sign up to see all Venture Life Group competitors and their valuation data.

Start Free Trial

Acquisitions by Venture Life Group

Venture Life Group has acquired 6 companies to date.

Last acquisition by Venture Life Group was on June 1st 2026. Venture Life Group acquired CUROXEN for $28M (EV/Revenue multiple available to Pro users).

See M&A valuation multiples

Latest Acquisitions by Venture Life Group

CUROXEN
FemiClear
BBI Healthcare
Pharma Source
Description
CUROXEN is a maker of first aid ointments. The company offers products including oxygenated olive oil and calendula for pain relief, infection prevention, and healing.
Femiclear is a company that offers over-the-counter women's health products addressing vaginal infections, irritation, odor, and related intimate-care needs.
BBI Healthcare is a Crumlin-based manufacturer developing continence care products including male guards, pads, pull-up pants, and institutional packs. The company produces absorbent solutions under the Select and Tena brands for distribution across the UK and Ireland. Its ISO 13485-certified facility in Northern Ireland focuses on dermatologically tested, odor-control products for moderate to heavy incontinence needs. BBI Healthcare supplies NHS trusts and pharmacies since 1989.
Pharma Source is a Netherlands-based distributor of pharmaceutical raw materials including APIs, solvents, and packaging components sourced from certified suppliers in India and China. Headquartered in Rotterdam since 1998, it supplies excipients like microcrystalline cellulose to Dutch contract manufacturers and adheres to EDQM standards for European markets.
HQ CountryUnited StatesUnited StatesUnited KingdomNetherlands
HQ City
Austin, TX
Austin, TX
Bridgend
Rotterdam
Deal Date1 Jun 20261 Jun 20267 Jun 202119 Dec 2019
Valuation$28M$28M$46M$7M
EV/Revenue
EV/EBITDA

This data is available for Pro users. Sign up to see all Venture Life Group acquisitions and their M&A valuation multiples.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Venture Life Group

When was Venture Life Group founded?Venture Life Group was founded in 2005.
Where is Venture Life Group headquartered?Venture Life Group is headquartered in United Kingdom.
How many employees does Venture Life Group have?As of today, Venture Life Group has over 58 employees.
Who is the CEO of Venture Life Group?Venture Life Group's CEO is Jeremy Anthony Philip Jerry Randall.
Is Venture Life Group publicly listed?Yes, Venture Life Group is a public company listed on London Stock Exchange.
What is the stock symbol of Venture Life Group?Venture Life Group trades under VLG ticker.
When did Venture Life Group go public?Venture Life Group went public in 2014.
Who are competitors of Venture Life Group?Venture Life Group main competitors include FitLife Brands, Chong Kun Dang Holdings, Vita Life Sciences, Promopharm, Hofseth BioCare, Hyundai Bioland Co, Enzymatica, Biome Australia, Provexis, Niagen Bioscience.
What is the current market cap of Venture Life Group?Venture Life Group's current market cap is $113M.
What is the current revenue of Venture Life Group?Venture Life Group's last 12 months revenue is $50M.
What is the current revenue growth of Venture Life Group?Venture Life Group revenue growth (NTM/LTM) is 49%.
What is the current EV/Revenue multiple of Venture Life Group?Current revenue multiple of Venture Life Group is 1.4x.
What is the current EBITDA of Venture Life Group?Venture Life Group's last 12 months EBITDA is $9M.
What is Venture Life Group's EBITDA margin?Venture Life Group's last 12 months EBITDA margin is 18%.
What is the current EV/EBITDA multiple of Venture Life Group?Current EBITDA multiple of Venture Life Group is 7.7x.
What is the current FCF of Venture Life Group?Venture Life Group's last 12 months FCF is $7M.
What is Venture Life Group's FCF margin?Venture Life Group's last 12 months FCF margin is 13%.
What is the current EV/FCF multiple of Venture Life Group?Current FCF multiple of Venture Life Group is 10.2x.
How many companies Venture Life Group has acquired to date?As of July 2026, Venture Life Group has acquired 6 companies.
What was the largest acquisition by Venture Life Group?$46M acquisition of BBI Healthcare on 7th June 2021 was the largest M&A Venture Life Group has done to date.
What companies Venture Life Group acquired?Venture Life Group acquired BBI Healthcare, CUROXEN, FemiClear, Pharma Source, UltraDEX, and Biokosmes.
In how many companies Venture Life Group has invested to date?Venture Life Group hasn't invested in any companies yet (or none have been disclosed publicly).

See public comps similar to Venture Life Group

Lists including Venture Life Group

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial